Page 2 - While Laboratory Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Citigroup downgraded shares of Laboratory Co. of America from a "buy" rating to a "neutral" rating in a report on Monday.

Laboratory Co. of America Holdings (NYSE:LH - Get Rating) has received an average rating of "Moderate Buy" from the eleven ratings firms that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and five have given a buy

Laboratory Co. of America Holdings (NYSE:LH - Get Rating) has been assigned an average rating of "Moderate Buy" from the eleven ratings firms that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and four ha

Laboratory Co. of America Holdings (NYSE:LH - Get Rating) was the recipient of a significant growth in short interest in September. As of September 15th, there was short interest totalling 1,840,000 shares, a growth of 18.7% from the August 31st total of 1,550,000 shares. Approximately 2.0% of the shares of the company are short sold. Based on an average daily trading volume, of 577,800 shares, the short-interest ratio is presently 3.2 days.

Laboratory Co. of America Holdings (NYSE:LH - Get Rating) - Research analysts at Zacks Research cut their FY2023 EPS estimates for Laboratory Co. of America in a research note issued on Wednesday, September 21st. Zacks Research analyst B. Das now anticipates that the medical research company will